Trump has claimed the company delayed an announcement for its vaccine until after the 2020 presidential election.
Pfizer (NYSE:PFE) and other pandemic-era favorites will be back in the investors’ crosshairs following the resignation of Dr.
The inquiry is looking into a politically explosive suggestion that Pfizer delayed announcing a successful vaccine against ...
The report said GSK’s former head of vaccine development, Philip Dormitzer, who joined the company after working at ...
The United States led the world in developing the technology that beat the COVID-19 pandemic. Action from lawmakers may leave ...
In his resignation letter, Marks wrote that health secretary Robert F. Kennedy Jr. wanted "subservient confirmation of his ...
Rep. Marjorie Taylor Greene calls for yanking FDA approval of COVID-19 vaccines, says that "COVID-19 vaccines are causing ...
Pfizer (NYSE:PFE) shares fell on Wednesday ... deliberately delayed announcing the success of its Covid vaccine developed with BioNTech (NASDAQ:BNTX). The probe follows a claim made by a former ...
Scientists say that officials from the National Institutes of Health urged them to remove references to mRNA vaccine ...
In a legal battle between BioNTech and CureVac, the European Patent Office declared a patent owned by CureVac ...
There were also no differences in birth defect risk between either the Moderna and the Pfizer/BioNTech vaccines, researchers ...
The ruling was 5-2 along party lines, with all the Republicans in the majority and all the Democrats dissenting. Chief ...